Jesse Brodkin - Concepedia

Author

Jesse Brodkin

General Atomics (United States)

Also Known As

J Brodkin, J. Brodkin, Jennifer Brodkin, Jesse Brodkin, Jesse D Brodkin, Jesse D. Brodkin

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

General Atomics (United States)Case Western Reserve University Merck & Co., Inc., Rahway, NJ, USA (United States)Eli Lilly (United States)National Institute of Diabetes and Digestive and Kidney Diseases

About

Jesse Brodkin is an author at General Atomics (United States) specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.9K
2	Social Sciences	7	7	1.1K
3	Health Sciences	1	1	21
4	Public Health	1	1	92
5	Biochemistry	1	1	73

Jesse Brodkin

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]- pyridine: A Potent and Highly Selective Metabotropic Glutamate Subtype 5 Receptor Antagonist with Anxiolytic Activity Nicholas D. P. Cosford, Lida Tehrani, Jeffrey Roppe, Journal of Medicinal Chemistry Receptor AntagonistPsychopharmacologyPharmacotherapyCompound 9Off-target Activity	2002	400
Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice Jesús Gomeza, Harlan E. Shannon, Evi Kostenis, Proceedings of the National Academy of Sciences PharmacotherapyExperimental PharmacologyCellular PhysiologyMolecular PharmacologyMolecular Signaling	1999	350
Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M <sub>4</sub> muscarinic acetylcholine receptor knockout mice Jesús Gomeza, Lu Zhang, Evi Kostenis, Proceedings of the National Academy of Sciences Synaptic TransmissionNeurotransmitterMuscarinic Acetylcholine ReceptorsLocomotor ActivityNeurotransmission	1999	319
The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety Chris S Busse, Jesse Brodkin, David Tattersall, Neuropsychopharmacology PsychiatryBehavioral NeuroscienceMedicineBehavioural PharmacologyRodent Models	2004	157
Anxiolytic-like activity of the mGluR5 antagonist MPEPA comparison with diazepam and buspirone Jesse Brodkin, Chris S Busse, Stacey J. Sukoff Rizzo, Pharmacology Biochemistry and Behavior Anxiolytic-like ActivityMedicinePsychotropic MedicationMechanism Of ActionNeuropharmacology	2002	144
Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors. J. Frank Nash, Jesse Brodkin Journal of Pharmacology and Experimental Therapeutics	1991	125
Reduced stress‐induced hyperthermia in mGluR5 knockout mice Jesse Brodkin, Margaret Bradbury, Chris S Busse, European Journal of Neuroscience	2002	95
Validation and implementation of a novel high-throughput behavioral phenotyping instrument for mice Jesse Brodkin, Dana M. Frank, Ryan M. Grippo, Journal of Neuroscience Methods Knockout MousePhenomicsXenotransplantationBehavioral NeuroscienceRodent Models	2014	92
SR141716A Antagonizes the Disruptive Effects of Cannabinoid Ligands on Learning in Rats Jesse Brodkin, Joseph M. Moerschbaecher Journal of Pharmacology and Experimental Therapeutics	1997	88
Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression Susan M. Ferguson, Jesse Brodkin, G. Kenneth Lloyd, Psychopharmacology PsychiatryMood SymptomAntidepressant-like EffectsMedicineNicotine	2000	85

Page 1